Drug Database
Back to search

United States· US:71715-002_52cb2b5d-4a13-8b4a-e063-6294a90ad5b1

NUZYRA

A omadacycline product containing omadacycline, registered in United States by Paratek Pharmaceuticals, Inc..

ATC J01AA15US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNUZYRAATCJ01AA15REGISTER NO.US:71715-002_52cb2b5d…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about omadacyclineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OMADACYCLINE
Manufacturer
Paratek Pharmaceuticals, Inc.
Country
United States (US)
ATC code
J01AA15
ATC class
Omadacycline
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    7171500221
    1 BLISTER PACK in 1 CARTON (71715-002-21) / 6 TABLET, FILM COATED in 1 BLISTER PACK (71715-002-28)
  • ndc11
    7171500227
    5 BLISTER PACK in 1 CARTON (71715-002-27) / 6 TABLET, FILM COATED in 1 BLISTER PACK (71715-002-28)
  • ndc11
    71715-002-21
  • ndc11
    71715-002-27

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

64 interactions on record for omadacycline.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check omadacycline against other medicinesHow interaction checks work

Omadacycline · interactions on record

64 records

  • 6 severe
  • 58 moderate

Most severe, free to view

  • AcitretinD05BB02severe
  • IsotretinoinD10AD04severe
  • IsotretinoinD10BA01severe
  • Aminolevulinic acidL01XD04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01AA15

Omadacycline, as other registers publish it.

All omadacycline products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d4b9656a-6b2a-443d-ac27-a6a35c84d717
GET /v1/drugs/d4b9656a-6b2a-443d-ac27-a6a35c84d717?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "150",
  "substance": "OMADACYCLINE",
  "productndc": "71715-002",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA209816",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about omadacycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console